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Available online 18 September 2008The authors are to be congratulated on producing such
a comprehensive review of the literature on deep vein
thrombosis and its prevention after arterial surgery. The
most striking aspect of this review is just how inadequate
and confusing the literature on the subject is. In particular,
numerous definitions of and techniques for diagnosing deep
vein thrombosis have been used and Table 1 clearly
demonstrates to the reader the paucity of randomised
controlled trials. The largest number of patients rando-
mised in the six controlled trials reviewed is 400. However,
it has been calculated that the number of patients required
to be randomised if it might be expected that subcutaneous
heparin halved the rate of venous thromboembolism (VTE)
would be 500 for deep vein thrombosis, 5000 for pulmonary
embolism, 20,000 for fatal pulmonary embolism and
100,000 to show an effect on total mortality.1 The first
randomised controlled study to show a significant reduction
in the incidence of VTE in general surgical patients
recruited 4471 patients.2 Therefore, the conclusion that I
draw from this review is that no conclusion can be drawn.
This is primarily because the relevant randomised
controlled trials are pitifully underpowered.DOI of original article: 10.1016/j.ejvs.2008.07.007.
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doi:10.1016/j.ejvs.2008.07.013So where does this leave the practising vascular surgeon
in his/her attempt to minimise the incidence of VTE in
patients undergoing arterial surgery? Nearly all patients
undergoing vascular surgery are taking anti-platelet agents
which should not be stopped around the time of surgery
because such agents reduce the incidence of perioperative
cardiac and cerebrovascular events.3 There is no evidence
that anti-platelet agents decrease the incidence of post-
operative VTE,4 yet they do increase the risk of bleeding. As
the authors explain in their review, it is assumed by many
vascular surgeons that the use of intravenous heparin
reduces the incidence of postoperative thromboembolism.
However, there is no evidence for this assumption. The
dilemma for the vascular surgeon therefore is that the
nature of the surgery itself plus the use of an anti-platelet
agent combined with preoperative prophylactic subcuta-
neous heparin will increase the risk of bleeding. On the other
hand, numerous authoritative guidelines for the prevention
of VTE indirectly categorise arterial surgical patients into
high-risk groups and therefore effectively recommend that
such patients should receive heparin thromboprophylaxis.
Thus, the vascular surgeon is trapped between the desire to
reduce the incidence of VTE in his/her arterial surgical
patients whilst not wanting to increase the risk of bleeding
or fall foul of the potential medico-legal consequences of
failure to provide effective VTE prophylaxis.
Although as the authors argue, the ideal answer to this
dilemma is a large-scale adequately powered prospectived by Elsevier Ltd. All rights reserved.
Deep Vein Thrombosis after Arterial Surgery 575randomised trial, it would not be ethical to randomise
a control group with no prophylaxis. Therefore, in my
opinion the only approach the vascular surgeons can take is
to transpose the evidence from VTE prophylaxis in general
surgical patients to their arterial surgery practice. I will
summarise my own approach in the following paragraphs.
Unfortunately, my views cannot be evidence-based, but
rather a distillation of what I consider to be the pertinent
information from general surgical trials.
There is considerable evidence that TED stockings and
intraoperative intermittent pneumatic compression (IPC)
reduce postoperative VTE.5 In arterial patients with
palpable peripheral pulses these methods should be used
and in those without peripheral pulses the ankle pressure
should be measured. If they are >100 mmHg then it should
be safe to apply TED stockings. This calculation assumes
that the compression pressure of TED stockings at the ankle
is 20 mmHg5 and a minimum arterial perfusion pressure of
80 mmHg at the ankle is adequate. With regard to IPC, if
there is concern about the vascular supply to the leg, then
whilst the IPC boots are applied in theatre it is straight-
forward to investigate with a pencil Doppler whether or not
the ankle signals disappear during the compressive phase.
With regard to carotid artery surgery it is widely
accepted that neck surgery is low risk for VTE and high risk
for bleeding. I therefore only use TED stockings and IPC
prophylaxis in these patients. Amputation patients are
particularly high-risk group because of pre- and post-
operative immobility. I therefore use preoperative low
molecular weight heparin, a TED stocking and IPC. In the
case of patients undergoing lower limb reconstructive
surgery or aortic surgery, in addition to the physicalmethods mentioned above, I prescribe low molecular
weight heparin starting preoperatively. If, however, the
surgeon is particularly concerned about the risk of intra-
operative bleeding, it has been shown that low molecular
weight heparin started up to 10 h postoperatively is as
effective as that started 2 h preoperatively.6 Thus, low
molecular weight heparin can be started up to 10 h after
surgery in these patients without increasing the risk of
intraoperative bleeding. An additional advantage of this
approach is that concerns regarding the timing of epidural
placement after low molecular weight heparin administra-
tion are negated.
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